Clinical trial · Observational
Observational Study on the Management of Patients With Non Small Cell Lung Cancer Adenocarcinoma
Observational Study on the Management of Patients With Non Small Cell Lung Cancer (NSCLC) Adenocarcinoma Tested for the Activating Mutation of Epidermal Growth Factor Receptor Tyrosine Kinase (EGFR TK)
NCT01167972CI-TRIAL-00007998MUTACTcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The main objective of the study is to determine the proportion of patients with M + mutation status among patients with Non Small Cell Lung Cancer adenocarcinoma.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Non Small Cell Lung Cancer | Lung Non-Small Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- 1
Primary outcomes (1)
- measure
- The main objective of the study is to determine the proportion of patients with M + mutation status among patients with NSCLC adenocarcinoma
- timeFrame
- At baseline
Secondary outcomes (3)
- measure
- Describe the therapeutic management according to the mutational status (EGFR M +, EGFR M- and Mx).
- timeFrame
- 12 months / At each visit
- measure
- Describe the therapeutic management of patients with EGFR M +.
- timeFrame
- 12 months / At each visit
- measure
- Describe the clinical course of patients EGFR-M +, treated for first-line treatment, and then 2nd line treatment, until 31-AUG-2012
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patient with lung cancer (Non Small Cell Lung Cancer adenocarcinoma) * Patient for whom a search for the mutational status of EGFR (EGFR-M +, M- or Mx) has been done or is being analyzed Exclusion Criteria: * Assessment of mutational status of EGFR is not done
References
Publications (0)
Data not yet available
No reference posted for this study.